Food-Grade Saponin Extract as an Emulsifier and Immunostimulant in Emulsion-Based Subunit Vaccine for Pigs

被引:11
作者
Burakova, Yulia [1 ,2 ]
Madera, Rachel [1 ]
Wang, Lihua [1 ]
Buist, Sterling [1 ]
Lleellish, Karen [1 ]
Schlup, John R. [2 ]
Shi, Jishu [1 ]
机构
[1] Kansas State Univ, Coll Vet Sci, Dept Anat & Physiol, 228 Coles Hall,1620 Denison Ave, Manhattan, KS 66506 USA
[2] Kansas State Univ, Coll Engn, Dept Chem Engn, 1005 Durland Hall,1701A Platt St, Manhattan, KS 66506 USA
关键词
CLASSICAL SWINE-FEVER; MOUTH-DISEASE VACCINE; ADJUVANT; VIRUS; QS-21; STABILITY; QUIL;
D O I
10.1155/2018/8979838
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Subunit vaccines consisting of highly purified antigens require the presence of adjuvants to create effective and long-lasting protective immunity. Advances on adjuvant research include designing combination adjuvants which incorporate two or more adjuvants to enhance vaccine efficacy. Previously, an oil-in-water emulsion adjuvant (OW-14) composed of mineral oil and an inexpensive gum Arabic emulsifier has been reported demonstrating enhanced and robust immune responses when used as an adjuvant in swine subunit vaccines. This study presents a modified version of OW-14 prepared with food-grade Quillaja saponin extract (OWq). In new OWq emulsion, saponin extract served as an emulsifier for stabilization of emulsion droplets and as an immunoactive compound. The use of saponins allowed to reduce the required amount of emulsifier in the original OW-14. However, emulsion stabilized with saponins demonstrated extended physical stability even at elevated temperature (37 degrees C). The two-dose vaccination with a classical swine fever virus (CSFV) glycoprotein E2-based vaccine formulated with OWq produced higher levels of E2-specific IgG and virus neutralizing antibodies in pigs in contrast with animals that received the vaccine adjuvanted with oil only. In addition, new OWq adjuvant was safe to use in the vaccination of pigs.
引用
收藏
页数:8
相关论文
共 24 条
[1]   Vaccine delivery to animals [J].
Bowersock, TL ;
Martin, S .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 38 (02) :167-194
[2]   Adjuvants for Animal Vaccines [J].
Burakova, Yulia ;
Madera, Rachel ;
McVey, Scott ;
Schlup, John R. ;
Shi, Jishu .
VIRAL IMMUNOLOGY, 2018, 31 (01) :11-22
[3]   QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle [J].
Cokcaliskan, Can ;
Turkoglu, Tuncer ;
Sareyyupoglu, Beyhan ;
Uzunlu, Ergun ;
Babak, Ayca ;
Ozbilge, Banu B. ;
Gulyaz, Veli .
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2016, 5 (02) :138-147
[4]   Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis [J].
Fernandez-Tejada, Alberto ;
Tan, Derek S. ;
Gin, David Y. .
ACCOUNTS OF CHEMICAL RESEARCH, 2016, 49 (09) :1741-1756
[5]   Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines [J].
Galliher-Beckley, A. ;
Pappan, L. K. ;
Madera, Rachel ;
Burakova, Y. ;
Waters, A. ;
Nickles, M. ;
Li, X. ;
Nietfeld, J. ;
Schlup, J. R. ;
Zhong, Q. ;
McVey, S. ;
Dritz, S. S. ;
Shi, J. .
VACCINE, 2015, 33 (25) :2903-2908
[6]   Structure- and oil type-based efficacy of emulsion adjuvants [J].
Jansen, Theo ;
Hofmans, Marij P. M. ;
Theelen, Marc J. G. ;
Manders, Frans ;
Schijns, Virgil E. J. C. .
VACCINE, 2006, 24 (26) :5400-5405
[7]   Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response [J].
Kanchan, Vibhu ;
Panda, Amulya K. .
BIOMATERIALS, 2007, 28 (35) :5344-5357
[8]  
KENSIL CR, 1991, J IMMUNOL, V146, P431
[9]  
Kensil CR, 1996, CRIT REV THER DRUG, V13, P1
[10]   Veterinary and human vaccine evaluation methods [J].
Knight-Jones, T. J. D. ;
Edmond, K. ;
Gubbins, S. ;
Paton, D. J. .
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2014, 281 (1784)